A5060038131- Acute Myeloid Leukemia Research
- Palliative Care and End-of-Life Issues
- Neutropenia and Cancer Infections
- Histone Deacetylase Inhibitors Research
- Acute Lymphoblastic Leukemia research
- Hematological disorders and diagnostics
- Hematopoietic Stem Cell Transplantation
- Head and Neck Cancer Studies
- Economic and Financial Impacts of Cancer
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Vitamin C and Antioxidants Research
- Pleural and Pulmonary Diseases
- Erythropoietin and Anemia Treatment
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Respiratory Support and Mechanisms
- SARS-CoV-2 and COVID-19 Research
- Management of metastatic bone disease
- Surgical site infection prevention
- Multiple and Secondary Primary Cancers
- Pneumothorax, Barotrauma, Emphysema
- Reconstructive Surgery and Microvascular Techniques
- Vasculitis and related conditions
- Fungal Infections and Studies
- Immune responses and vaccinations
University of Minnesota
2024-2025
The University of Texas Southwestern Medical Center
2020-2024
University of Minnesota Medical Center
2024
University of Minnesota System
2024
Southwestern Medical Center
2020-2024
Harold C. Simmons Comprehensive Cancer Center
2023
Mount Sinai Hospital
2019-2021
Sidney Kimmel Comprehensive Cancer Center
2020
Johns Hopkins University
2020
St. Luke's-Roosevelt Hospital Center
2018-2019
This survey study assesses patterns of use and costs medical equipment among US cancer survivors.
"CRE25-042: Advanced Fibrosis, TP53 Variants, and Erythroid Differentiation: Diagnostic Harbingers of ERCC6L2-Related Bone Marrow Failure Syndrome?" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Aim: The neutropenic diet is commonly prescribed to cancer patients with neutropenia the goal of reducing infections. However, multiple randomized trials have proved no benefit diets compared less restricted regards infectious risk. We aimed ascertain if top centers recommended for or against use on their official websites. Methods: reviewed websites 20 hospitals in 2017 US News Best Hospitals Cancer©, and ascertained recommendations (for, against, equivocal, not addressed). Results: Seven...
This cohort study assesses the racial differences in rates of autopsy groups decedents older than 18 years from 2008 to 2017 US Centers for Disease Control and Prevention Wide-Ranging Online Data Epidemiologic Research database.
Background: The novel corona virus has changed the way individuals interact with each other and society. In medical sector, this affected residents fellows who spend majority of their time on front lines.Methods: We conducted a cross-sectional survey to assess impact COVID-19 pandemic lives training house-staff across USA. Respondents in our reported feeling significantly overwhelmed by ongoing pandemic.Results: were concerned about lack protective equipment, inability safeguard themselves...
Background: There has been an overall decline in intensive care unit mortality over the past 2 decades, including patients undergoing intubation and mechanical ventilation (MV). Whether this extends to with metastatic cancer remains unknown. We analyzed outcomes of intubation/MV using National Hospital Discharge Survey (NHDS) database from 2001 2010. Methods: Diagnosis procedure codes were used identify who underwent intubation/MV. Demographics, diagnoses, length stay (LOS), discharge...
401 Background: Pancreatic enzyme replacement therapy (PERT) can reduce symptoms of indigestion and improve nutrition in patients with exocrine pancreatic insufficiency. PERT is under-prescribed, this may be related to actual costs prescriber sensitivity these costs. Thus, we aimed assess Methods: We used Medicare Part D formulary pricing files for the first quarter 2020 conduct a patient-level modeling study describe point-of-sale out-of-pocket each formulation among stand-alone Advantage...
Background: Opioid-induced constipation (OIC) remains the most common adverse event associated with opioid use. Treatment more novel and costly agents (such as peripheral μ-opioid receptor antagonists [PAMORAs]) may be indicated in patients laxative-refractory OIC. Three PAMORAs are U.S. Food Drug Administration approved for managing OIC—methylnaltrexone (FDA 2008), naloxegol (in 2014), naldemedine 2017). These drugs only limited scenarios. Their contemporary patterns of use burden spending...
210 Background: Cancer survivors are increasingly older, with rising rates of functional impairment, comorbidity burden, and needs. Patients often require medical equipment, but administrative barriers lack payer coverage can limit access increase cost sharing for patients. Prior work on financial burdens has largely focused direct costs prescription drugs. We sought to characterize patterns use associated equipment among US cancer survivors. Methods: used the National Health Interview...
To study the influence of Affordable Care Act (ACA) policy and its Medicaid expansion on insurance status survival in patients with HIV aggressive lymphoma.
Introduction: Aging and inflammation are both important risk factors of heart failure with preserved ejection fraction (HFpEF). However, a potential mechanistic link between them in HFpEF pathogenesis remains unknown. Clonal hematopoiesis indeterminate (CHIP) is common age-related condition characterized by the clonal expansion hematopoietic stem cell (HSCs) bearing mutations certain driver genes associated increased elevated cardiovascular diseases. our understanding role CHIP limited....
Rituximab and prednisone are commonly used treatments for autoimmune hemolytic anemia (AIHA), where the body's immune system attacks destroys its red blood cells. However, some AIHA patients may become refractory to rituximab treatment, this can result in continued hemolysis persistent anemia, making it challenging affected individuals manage their symptoms. The underlying causes of refractoriness be complex vary from patient patient. Herein, we present a case newly diagnosed warm cold that...
Introduction: HIV-associated lymphomas affect a uniquely disadvantaged group of patients, who were often denied insurance based on preexisting conditions until the Affordable Care Act (ACA) was signed in 2010. We investigated impact ACA and its Medicaid expansion 2014 which covered low-income strata, outcomes among patients with aggressive B-cell non-Hodgkin (HIV-aB-NHL). Methods: used National cancer database (NCDB) to identify aB-NHL aged 18–64 years from 2004 2017. defined pre-ACA period...